http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010108002-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-30 |
| filingDate | 2008-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010108002-A |
| titleOfInvention | DERIVATIVES OF BENZAMIDE, THEIR PRODUCTION AND USE IN MEDICINE |
| abstract | 1. The compounds of formula (I) or their pharmaceutically acceptable salts:! ! where R1 represents alkyl; ! R2 is; and! n is an integer from 1 to 5.! 2. The compounds or their pharmaceutically acceptable salts according to claim 1, where R1 represents methyl, ethyl or isopropyl. ! 3. The compounds or their pharmaceutically acceptable salts according to claim 1 or 2, where n is an integer from 1 to 3.! 4. The compounds or their pharmaceutically acceptable salts according to claim 1 or 2, including the compounds of formula (IA) or their pharmaceutically acceptable salts:! ! where R1, R2, n are as defined in claim 1. ! 5. The compounds or their pharmaceutically acceptable salts according to claim 1 or 2, including the compounds of formula (IB) or their pharmaceutically acceptable salts:! ,! where R1, R2, n are as defined in claim 1. ! 6. The compounds or their pharmaceutically acceptable salts according to claim 1 or 2, where these salts are salts formed with acids selected from the group consisting of hydrochloric acid, methanesulfonic acid, sulfuric acid, tartaric acid, citric acid, acetic acid and trifluoroacetic acid. ! 7. The compounds or their pharmaceutically acceptable salts according to claim 1, including:! ! ! and. ! 8. The method of obtaining the compounds of formula (I) according to claim 1, including:! ! reacting azidomethyl-morpholine trifluoroacetate with Br-CH2- (CH2) n-CH2-C (O) OEt under alkaline conditions to obtain an N-substituted azidomethyl-morpholine; ! ! recovering the obtained N-substituted azidomethyl-morpholine by hydrogenation to obtain N-substituted aminomethyl-morpholine; ! ! interaction of N-substituted aminomethyl-morpholine with substituted benzoic acid in the presence of |
| priorityDate | 2007-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.